Balchem Corporation (BCPC)
BCPCNASDAQ-GSMajor Chemicals
$175.99
0.0000 (0.00%) today
At the close, Nov 9, 4:00 PM ET. Pre-market $175.99 –
- Market cap
- $5.59bn
- P/E
- 30.9
- EPS, last 4 quarters
- $5.70
- Dividend yield
- 0.55%
- Day range
- –
- 52-week range
- $147.18 to $186.15
- Average volume
- 266.7k
- Previous close
- $175.99
Analysts
1 coveringHold1 buy, 0 hold, 0 sell
Targets a year out average $210.00, +19.3% from here
Earnings
next estimate $1.47Next report
Dec 2025
+1.6%
Mar 2026
0.0%
Jun 2026
+6.4%
Sep 2026
+1.9%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $263.62m | $270.71m | $284.00m | $290.66m |
| Gross profit | $93.90m | $101.08m | $103.68m | $105.71m |
| Operating income | $52.29m | $55.63m | $59.22m | $62.44m |
| Net income | $39.23m | $40.28m | $44.62m | $46.73m |
Last four quarters: revenue $1.11bn, margin 15.4%, free cash flow $178.00m
News
8 latest- 3 Companies With Room to Pass on Costs to Manage InflationMarketBeat · Oct 26, 2026
- Balchem: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · Oct 23, 2026
- Balchem (BCPC) Q3 2026 Earnings Call TranscriptThe Motley Fool · Oct 23, 2026
- Balchem Corporation Reports Third Quarter 2026 net sales of $290.7 million and net earnings of $46.7 millionFintel · Oct 23, 2026
- Balchem Corp. Q3 Income Rises RTTNews · Oct 23, 2026
- Quaker Chemical (KWR) Q2 Earnings and Revenues Surpass EstimatesZacks · Jul 30, 2026
- Sensient Technologies (SXT) Surpasses Q2 Earnings and Revenue EstimatesZacks · Jul 24, 2026
- Hudbay Minerals Expands Constancia Mill Capacity With Permit Approval Zacks · Jul 3, 2026
The company
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
- Sector
- Industrials
- Industry
- Major Chemicals
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- balchem.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.